Paulson & Co’s Eli Lilly LLY Stock Holding History

Paulson & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-45,800	Closed	-$3.68M	–	108
2016 Q3	$3.68M	Buy	+45,800	New	+$3.67M	0.04%	77

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Paulson & Co's LLY Position: Q4 2016 in Review

Paulson & Co sold out of Eli Lilly (LLY) in Q4 2016, closing a stake of 45,800 shares — an estimated $3.68M sold.

Paulson & Co first reported a position in LLY in Q3 2016 and held it in 1 quarter. The position peaked at $3.68M in Q3 2016. 1,212 funds tracked by Wall St. Rank hold LLY as of Q4 2016.

Paulson & Co reported no remaining Eli Lilly position as of Q4 2016 after selling out during the quarter.
Paulson & Co sold 45,800 Eli Lilly shares in Q4 2016, an estimated $3.68M.
Paulson & Co first reported a position in Eli Lilly in Q3 2016 and held it in 1 quarter.
Paulson & Co's Eli Lilly position peaked at $3.68M in Q3 2016.
1,212 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2016.

Based on Paulson & Co's 13F filing for Q4 2016, filed 14 Feb 2017.